Double Medical Technology Inc Cash Flow Conversion Efficiency
Double Medical Technology Inc cash flow conversion efficiency. Based on the latest financial reports, Double Medical Technology Inc (002901) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥207.34 Million ≈ $30.34 Million USD) by net assets (CN¥3.44 Billion ≈ $503.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Double Medical Technology Inc (2013–2025)
Cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2025. This chart illustrates how Double Medical Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Double Medical Technology Inc (002901) stock price for real-time trading data and today's change.
Double Medical Technology Inc Cash Flow Conversion Ratio Explained
Double Medical Technology Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Double Medical Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Double Medical Technology Inc ranked by their cash flow conversion efficiency. Also see Double Medical Technology Inc (002901) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bumi Resources Tbk
JK:BUMI
|
-0.009x |
|
Companhia de Gás de São Paulo - COMGÁS
SA:CGAS3
|
0.555x |
|
Taihan Electric Wire Co Ltd
KO:001440
|
-0.054x |
|
Empresas CMPC
SN:CMPC
|
0.007x |
|
Kalpataru Projects International Ltd.
NSE:KPIL
|
-0.053x |
|
TransMedics Group Inc
NASDAQ:TMDX
|
0.033x |
|
F&G Annuities & Life Inc.
NYSE:FG
|
0.317x |
|
Curaleaf Holdings Inc.
TO:CURA
|
0.055x |
Annual Cash Flow Conversion Efficiency for Double Medical Technology Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2025. Review 002901 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.69 Billion ≈ $539.27 Million |
CN¥831.34 Million ≈ $121.65 Million |
0.226x | +62.27% |
| 2024-12-31 | CN¥3.18 Billion ≈ $465.57 Million |
CN¥442.30 Million ≈ $64.72 Million |
0.139x | +494.63% |
| 2023-12-31 | CN¥3.16 Billion ≈ $462.50 Million |
CN¥73.89 Million ≈ $10.81 Million |
0.023x | -43.46% |
| 2022-12-31 | CN¥3.11 Billion ≈ $454.56 Million |
CN¥128.44 Million ≈ $18.80 Million |
0.041x | -84.10% |
| 2021-12-31 | CN¥2.59 Billion ≈ $378.76 Million |
CN¥673.26 Million ≈ $98.52 Million |
0.260x | -0.13% |
| 2020-12-31 | CN¥2.13 Billion ≈ $312.26 Million |
CN¥555.77 Million ≈ $81.33 Million |
0.260x | +5.26% |
| 2019-12-31 | CN¥1.75 Billion ≈ $256.59 Million |
CN¥433.88 Million ≈ $63.49 Million |
0.247x | +7.72% |
| 2018-12-31 | CN¥1.46 Billion ≈ $213.33 Million |
CN¥334.88 Million ≈ $49.00 Million |
0.230x | -7.84% |
| 2017-12-31 | CN¥1.24 Billion ≈ $181.24 Million |
CN¥308.70 Million ≈ $45.17 Million |
0.249x | -30.19% |
| 2016-12-31 | CN¥580.13 Million ≈ $84.89 Million |
CN¥207.13 Million ≈ $30.31 Million |
0.357x | +27.78% |
| 2015-12-31 | CN¥441.78 Million ≈ $64.65 Million |
CN¥123.44 Million ≈ $18.06 Million |
0.279x | -49.27% |
| 2014-12-31 | CN¥274.36 Million ≈ $40.15 Million |
CN¥151.12 Million ≈ $22.11 Million |
0.551x | +16.16% |
| 2013-12-31 | CN¥224.61 Million ≈ $32.87 Million |
CN¥106.51 Million ≈ $15.59 Million |
0.474x | -- |
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying J… Read more